Late cytopenia after CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a Cell Therapy Consortium analysis.
- DOI
- 10.1182/bloodadvances.2026019953
- Published
- 2026 Sep 22
- Container
- Blood advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2026019953,
title = {Late cytopenia after CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a Cell Therapy Consortium analysis.},
author = {Wudhikarn K and Bromberg M and Brower J and Seshan V and Bachanova V and Ahmed S and McGuirk JP and Manu G and Maziarz RT and Oluwole OO and Schuster SJ and Porter DL and Bishop MR and Riedell PA and Perales MA and Dahi PB},
year = {2026},
journal = {Blood advances},
doi = {10.1182/bloodadvances.2026019953},
url = {https://doi.org/10.1182/bloodadvances.2026019953}
}RIS
TY - JOUR TI - Late cytopenia after CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a Cell Therapy Consortium analysis. AU - Wudhikarn K AU - Bromberg M AU - Brower J AU - Seshan V AU - Bachanova V AU - Ahmed S AU - McGuirk JP AU - Manu G AU - Maziarz RT AU - Oluwole OO AU - Schuster SJ AU - Porter DL AU - Bishop MR AU - Riedell PA AU - Perales MA AU - Dahi PB PY - 2026 JO - Blood advances DO - 10.1182/bloodadvances.2026019953 UR - https://doi.org/10.1182/bloodadvances.2026019953 ER -
APA
K, W., M, B., J, B., V, S., V, B., S, A., JP, M., G, M., RT, M., OO, O., SJ, S., DL, P., MR, B., PA, R., MA, P., & PB, D. (2026). Late cytopenia after CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a Cell Therapy Consortium analysis.. Blood advances. https://doi.org/10.1182/bloodadvances.2026019953
Source records
- pubmed · retrieved 2026-09-26T10:11:39.192Z